Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-17

Clinical Trial Update: Drug-drug Interaction Study [Phase 2]

View source ↗

Summary

Amicus Therapeutics completed a Phase 2 drug–drug interaction study in Pompe disease, and the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Amicus Therapeutics | Conditions: Pompe Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-08-17